How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has been a scorcher for much of the Northern Hemisphere. June and July marked ...
The last time 96-year-old Audrey Staniland was assessed for in-home aged care funding was with a human clinician more than a decade ago. When her daughter applied for a reassessment late last year, ...
OUR island is the last home of ignorant Euclidolatry; argal, a German scholar has been allowed to edit, and a German firm to publish, the best and only critical text of Euclid's works. Our ancient ...
We're sorry that you didn't have a completely satisfying visit. We'd love the opportunity to address any issues with our team here. Thank you for your time, and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...